David J Einstein (David Einstein)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Combination Therapy

Radical Prostatectomy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F Mcdermott, Mehmet Asim Bilen, Mark Stein, Jeffrey Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, David J Einstein, Paul J Catalano, Hans Hammers, Meredith M Regan
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). Journal for immunotherapy of cancer 12 (4) (2024)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F Mcdermott, Mehmet Asim Bilen, Mark Stein, Jeffrey Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, David J Einstein, Paul J Catalano, Hans Hammers, Meredith M Regan
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). Journal for immunotherapy of cancer 12 (4) (2024)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F Mcdermott, Mehmet Asim Bilen, Mark Stein, Jeffrey Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, David J Einstein, Paul J Catalano, Hans Hammers, Meredith M Regan
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). Journal for immunotherapy of cancer 12 (4) (2024)
Mannan Nouri, Andreas Varkaris, Maya Ridinger, Susan L Dalrymple, Christopher M Dennehy, John T Isaacs, David J Einstein, W Nathaniel Brennen, Steven P Balk
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer. Molecular cancer therapeutics (2024)
David J Einstein, Meredith M Regan, Julia S Stevens, David F McDermott, Ravi A Madan
Reply to B. Tombal et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mannan Nouri, Andreas Varkaris, Maya Ridinger, Susan L Dalrymple, Christopher M Dennehy, John T Isaacs, David J Einstein, W Nathaniel Brennen, Steven P Balk
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer. Molecular cancer therapeutics (2024)
David J Einstein, Meredith M Regan, Julia S Stevens, David F McDermott, Ravi A Madan
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
David J Einstein, Meredith M Regan, Julia S Stevens, David F McDermott, Ravi A Madan
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Zachary Quinn, Benjamin E Leiby, Guru P Sonpavde, Atish D Choudhury, Christopher J Sweeney, David J Einstein, Russell Zelig Szmulewitz, A Oliver Sartor, Beatrice Knudsen, Eddy Shih-Hsin Yang, William Kevin Kelly
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Daniel Sentana-Lledo, A Oliver Sartor, Steven P Balk, David J Einstein
Immune mechanisms behind prostate cancer in men of African ancestry: A review. The Prostate 82 (8) (2022)
Michael B Atkins, Opeyemi A Jagede, Naomi B Haas, David F McDermott, Mehmet A Bilen, Mark N Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael E Hurwitz, David J Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J Wu, David A Braun, David J Einstein, Paul J Catalano, Hans Hammers
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Jesse C Patterson, Andreas Varkaris, Peter J P Croucher, Maya Ridinger, Susan L Dalrymple, Mannan Nouri, Fang Xie, Shohreh Varmeh, Oliver Jonas, Matthew A Whitman, Sen Chen, Saleh Rashed, Lovemore Makusha, Jun Luo, John T Isaacs, Mark G Erlander, David J Einstein, Steven P Balk, Micheal B Yaffe
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling. Cancer research (2022)
Fen Ma, Seiji Arai, Keshan Wang, Carla Calagua, Amanda R Yuan, Larysa Poluben, Zhongkai Gu, Joshua W Russo, David J Einstein, Huihui Ye, Meng Xiao He, Yu Liu, Eliezer Van Allen, Adam G Sowalsky, Manoj K Bhasin, Xin Yuan, Steven P Balk
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer. Cancer research 82 (8) (2022)
Carla Calagua, Miriam Ficial, Caroline S Jansen, Taghreed Hirz, Luke Del Balzo, Scott Wilkinson, Ross Lake, Anson T Ku, Olga Voznesensky, David B Sykes, Philip J Saylor, Huihui Ye, Sabina Signoretti, Haydn Kissick, Adam G Sowalsky, Steven P Balk, David J Einstein
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
David J Einstein, Seiji Arai, Carla Calagua, Fang Xie, Olga Voznesensky, Brian J Capaldo, Christina Luffman, Jonathan L Hecht, Steven P Balk, Adam G Sowalsky, Joshua W Russo
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors. JCO precision oncology 5 (2021)
Shivanshu Awasthi, Anders E Berglund, Julieta Abraham-Miranda, Robert J Rounbehler, Kevin H Kensler, Amparo Serna, Adriana Vidal, Sungyong You, Michael R Freeman, Elai Davicioni, Yang Liu, R Jeffrey Karnes, Eric A Klein, Robert B Den, Bruce J Trock, Joshua D Campbell, David J Einstein, Raavi Gupta, Steven P Balk, Priti Lal, Jong Y Park, John L Cleveland, Timothy R Rebbeck, Stephen J Freedland, Kosj Yamoah
Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)